Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 2,001 | 24,449 | 1,530 | 8,787 | 2,645 |
| Gross Profit | 2,001 | 24,449 | 1,530 | 8,787 | 2,645 |
| Operating Expenses | 28,644 | 29,652 | 34,276 | 31,675 | 31,830 |
| Operating Income | -26,643 | -5,203 | -32,746 | -22,888 | -29,186 |
| Other Income | 1,627 | -1,436 | 2,565 | 1,382 | -4,949 |
| Pre-tax Income | -25,016 | -6,639 | -30,181 | -21,506 | -34,135 |
| Income Tax | N/A | N/A | 2,170 | N/A | N/A |
| Net Income Continuous | -25,016 | -6,639 | -32,351 | -21,506 | -34,135 |
| Net Income | $-25,016 | $-6,639 | $-32,351 | $-21,506 | $-34,135 |
| EPS Basic Total Ops | -3.24 | -0.84 | -4.32 | -3.00 | -4.68 |
| EPS Basic Continuous Ops | -3.25 | -0.87 | -4.29 | -2.99 | -4.71 |
| EPS Diluted Total Ops | -3.24 | -0.96 | -4.32 | -3.00 | -4.80 |
| EPS Diluted Continuous Ops | -3.25 | -0.87 | -4.29 | -2.98 | -4.71 |
| EBITDA(a) | $-25,449 | $-3,931 | $-31,389 | $-22,319 | $-27,937 |